Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: A randomized placebo-controlled trial

Addiction

Volumn 99, Issue 9, 2004, Pages 1206-1218

  Aubin, H J ^a,f   Lebargy, F ^b   Berlin, I ^c   Bidaut Mazel, C ^d   Chemali Hudry, J ^d   Lagrue, G ^e  

^a Emile Roux Hospital AP HP   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d GLAXOSMITHKLINE   (France)

^e Hopital Albert Chenevier   (France)

^f Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

Bupropion; European smokers smoking cessation; Predictors; Randomized clinical trial

Indexed keywords

AMFEBUTAMONE; ANTIVITAMIN K; CARBON MONOXIDE;

ADULT; ANXIETY DISORDER; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; EXPIRED AIR; FEMALE; FOLLOW UP; FRANCE; HEADACHE; HUMAN; MALAISE; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; OXYGEN THERAPY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; SWEATING; THORAX PAIN; TREMOR; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL DRINKING; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; MALE; MARITAL STATUS; MOTIVATION; PATIENT DROPOUTS; PREVALENCE; SEX FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 4544228943     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00814.x     Document Type: Article

References (46)

1. Alhuwalia, J. S., Harris, K. J., Catley, D., Okuyemi, K. S. & Mayo, M. S. (2002) Sustained release bupropion for smoking cessation in African Americans. A randomised controlled study. Journal of the American Medical Association, 288, 468-474.
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington. DC: American Psychiatric Association.
3. Aubin, H. J. (2002) Tolerability and safety of sustained-release bupropion in the management of smoking cessation. Drugs. 62, 45-52.
4. Beck, A. T. & Beamesderfer, A. (1974) Assessment of depression: the depression inventory. Modern Problems of Pharmacopsychiatry, 7, 151-169.
5. Beck, A. T. & Steer, R. A. (1978) Beck Depression Inventory. Philadelphia: Center for Cognitive Therapy.
6. Bolliger, C. T., Zellweger, J. P., Danielsson, T., van Biljon, X., Robidou, A., Westin, A., Perruchoud, A. P. & Sawe, U. (2000) Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ. 321, 329-333.
7. Breslau, N., Peterson, E., Schultz, L., Andreski, P. & Chilcoat, H. (1996) Are smokers with alcohol disorders less likely to quit? American Journal of Public Health, 86, 985-990.
8. Covey, L. S., Classman, A. H. & Stetner, F. (1998) Cigarette smoking and major depression. Journal of Addictive Diseases, 17, 35-46.
9. Curry, S., Thompson, B., Sexton, M. & Omenn, G. S. (1989) Psychosocial predictors of outcome in a worksite smoking cessation program. American Journal of Preventive Medicine, 5, 2-7.
10. Dale, L. C., Glover, E. D., Sachs, D. P., Schroeder, D. R., Offord, K. P., Croghan, I. T. & Hurt, R. D. (2001) Bupropion for smoking cessation: predictors of successful outcome. Chest. 119, 1357-1364.
11. Etter, J. F., Laszlo, E., Zellweger, J. P., Perrot, C. & Perneger, T. V. (2002) Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial. Journal of Clinical Psychopharmacology, 22, 487-495.
12. Ferry, L. H. & Burchette, R. J. (1994) Efficacy of bupropion for smoking cessation in non-depressed smokers. Journal of Addictive Diseases, 13, 249.
13. Fiore, M. C., Novotny, T. E., Pierce, J. P., Hatziandreu, E. J., Patel, K. M. & Davis, R. M. (1989) Trends in cigarette smoking in the United States. The changing influence of gender and race. Journal of the American Medical Association, 261, 49-55.
14. George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J. & Kosten, T. R. (2002) A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53-61.
15. Classman, A. H., Stetner, F., Walsh, B. T., Raizman, P. S., Fleiss, J., Cooper, T. B. & Covey, L. S. (1988) Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. Journal of the American Medical Association, 259, 2863-2866.
16. Gonzales, D., Bjornson, W., Durcan, M. J., White, J. D., Johnston, J. A., Buist, A. S., Sachs, D. P., Rigotti, N. A., Niaura, R., Hays. J. T. & Hurt, R. D. (2002) Effects of gender on relapse prevention in smokers treated with bupropion SR. American Journal of Preventive Medicine, 22, 234-239.
17. Hayford, K. E., Patten, C. A., Rummans, T. A., Schroeder, D. R., Offord, K. P., Croghan, I. T., Glover, E. D., Sachs, D. P. & Hurt, R. D. (1999) Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. British Journal of Psychiatry, 174, 173-178.
18. Hays, J. T., Hurt, R. D., Rigotti, N. A., Niaura, R., Gonzales, D., Durcan, M. J., Sachs, D. P., Wolter, T. D., Buist, A. S., Johnston, J. A. & White, J. D. (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation, a randomized, controlled trial, Annals of International Medicine, 135, 423-433.
19. Heatherton, T., Kozlowski, L. T., Frecker, R. C. & Fagerström, K. O. (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119-1127.
20. Howard, G., Wagenknecht, L. E., Burke, G. L., Diez-Roux, A., Evans, G. W., McGovern, P., Nieto, J. & Tell, G. S. for the ARIC investigators (1998) Cigarette smoking and progression of atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Journal of the American Medical Association, 279, 119-124.
21. Hughes, J. R., Goldstein, M. G., Hurt, R. D. & Shiffman, S. (1999) Recent advances in the pharmacotherapy of smoking. Journal of the American Medical Association, 281, 72-76.
22. Hughes, J. R., Stead, L. F. & Lancaster, T. (2002) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, 1, CD000031.
23. Humfleet, G., Munoz, R., Sees, K., Reus, V. & Hall, S. (1999) History of alcohol or drug problems, current use of alcohol or marijuana, and success in quitting smoking. Addictive Behaviors, 24, 149-154.
24. Hurt, R. D., Offord, K. P., Hepper, N. G., Mattson, B. R. & Toddie, D. A. (1988) Long-term follow-up of persons attending a community-based smoking-cessation program. Mayo Clinic Proceedings, 63, 681-690.
25. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., Croghan, I. T. & Sullivan, P. M. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine, 337, 1195-1202.
26. Hurt, R. D., Wolter, T. D., Rigotti, N., Hays, J. T., Niaura, R., Durcan, M. J., Gonzales, D., Sachs, D. P., Johnston, J. A. & Offord, K. P. (2002) Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome. Addictive Behaviors, 27, 493-507.
27. Hymowitz, N., Cummings, K. M., Hyland, A., Lynn, W. R., Pechacek, T. F. & Hartwell, T. D. (1997) Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tobacco Control. 6, S57-S62.
28. Jackson, P. H., Stapleton, J. A., Russell, M. A. & Merriman, R. J. (1986) Predictors of outcome in a general practitioner intervention against smoking. Preventive Medicine, 15, 244-253.
29. Jorenby, D. (2002) Clinical efficacy of bupropion in the management of smoking cessation. Drugs, 62, 25-35.
30. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., Fiore, M. C. & Baker, T. B. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685-691.
31. Killen, J. D., Fortmann, S. P., Kraemer, H. C., Varady, A. & Newman. B. (1992) Who will relapse? Symptoms of nicotine dependence predict long-term relapse after smoking cessation. Journal of Consulting and Clinical Psychology, 60, 797-801.
32. Lagrue, G., Légeron, P., Azoulaï, G., Pelissolo, S., Aubin, H. J. & Humbert, R. (2002) Elaboration d'un test permettant dévaluer la motivation à l'arrêt du tabac [Design of a test allowing the evaluation of motivation to stop smoking]. Alcoologie et Addictologie, 24, 33-37.
33. Little, R. J. A. & Rubin, D. B. (1987) Statistical Analysis with Missing Data. New York: Wiley.
34. Monsó, E., Campbell, J., Tønnesen, P., Gustavsson, G. & Morera, J. (2001) Sociodemographic predictors of success in smoking intervention. Tobacco Control, 10, 165-169.
35. Murray, R. P., Gerald, L. B., Lindgren, P. G., Connett, J. E., Rand, C. S. & Anthonisen, N. R. (2000) Characteristics of participants who stop smoking and sustain abstinence for 1 and 5 years in the Lung Health Study. Preventive Medicine, 30, 392-400.
36. Oei, T. P., Evans, L. & Crook, G. M. (1990) Utility and validity of the STAI with anxiety disorder patients. British Journal of Clinical Psychology, 29, 429-432.
37. Reinert, D. F. & Allen, J. P. (2002) The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcoholism: Clinical and Experimental Research, 26, 272-279.
38. Richmond, R. L., Kehoe, L. A. & Webster, I. W. (1993) Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction, 88, 1127-1135.
39. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R. & Dunbar, G. C. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22-33.
40. Stapleton, J. A., Russell, M. A., Feyerabend, C., Wiseman, S. M., Gustavsson, G., Sawe, U. & Wiseman, D. (1995) Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction, 90, 31-42.
41. Steinweg, D. L. & Worth, H. (1993) Alcoholism: the keys to the CAGE. American Journal of Medicine, 94, 520-523.
42. Tashkin, D. P., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M. A., Gonzales, D., Dozier, G., Patel, M. K. & Jamerson, B. D. (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet, 357, 1571-1575.
43. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives (2000) A clinical practice guideline for treating tobacco use and dependence. A US Public Health Service Report. Journal of the American Medical Association, 283, 3244-3254.
44. Tonstad, S. (2002) Use of sustained-release bupropion in specific patient populations for smoking cessation. Drugs, 62, 37-43.
45. Ward, K. D., Klesges, R. C., Zbikowski, S. M., Bliss, R. E. & Garvey, A. J. (1997) Gender differences in the outcome of an unaided smoking cessation attempt. Addictive Behaviors, 22, 521-533.
46. Wetter, D. W., Kenford, S. L., Smith, S. S., Fiore, M. C., Jorenby, D. E. & Baker, T. B. (1999) Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology, 67, 555-562.